Vascular cell lines expressing SSAO/VAP-1: A new experimental tool to study its involvement in vascular diseases

Biology of the Cell

Volumn 103, Issue 11, 2011, Pages 543-557

  Solé, Montse ^a   Unzeta, Mercedes ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cellular models; Endothelial cells; Inflammation; Primary amine oxidase (PrAo); Semicarbazide sensitive amine oxidase (SSAO) vascular adhesion protein 1 (VAP 1); Vascular pathology

Indexed keywords

VASCULAR ADHESION PROTEIN 1;

ARTICLE; CELL LINE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME KINETICS; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; LIPID RAFT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

AMINE OXIDASE (COPPER-CONTAINING); CELL ADHESION MOLECULES; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; MUSCLE, SMOOTH, VASCULAR; VASCULAR DISEASES;

EID: 81055149817     PISSN: 02484900     EISSN: 1768322X     Source Type: Journal    
DOI: 10.1042/BC20110049     Document Type: Article

References (50)

1. Abella, A., Garcia-Vicente, S., Viguerie, N., Ros-Baro, A., Camps, M., Palacin, M., Zorzano, A. and Marti, L. (2004) Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner. Diabetologia 47, 429-438
2. Andres, N., Lizcano, J.M., Rodriguez, M.J., Romera, M., Unzeta, M. and Mahy, N. (2001) Tissue activity and cellular localization of human semicarbazide-sensitive amine oxidase. J. Histochem. Cytochem. 49, 209-217
3. Boomsma, F., Derkx, F.H., van den Meiracker, A.H., Man in't Veld, A.J. and Schalekamp, M.A. (1995) Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin. Sci. 88, 675-679
4. Boomsma, F., van Veldhuisen, D.J., de Kam, P.J., Man in't Veld, A.J., Mosterd, A., Lie, K.I. and Schalekamp, M.A. (1997) Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc. Res. 33, 387-391
5. Conklin, D.J., Cowley, H.R., Wiechmann, R.J., Johnson, G.H., Trent, M.B. and Boor, P.J. (2004) Vasoactive effects of methylamine in isolated human blood vessels: role of semicarbazide-sensitive amine oxidase, formaldehyde, and hydrogen peroxide. Am. J. Physiol Heart Circ. Physiol 286, H667-H676
6. Conklin, D.J., Langford, S.D. and Boor, P.J. (1998) Contribution of serum and cellular semicarbazide-sensitive amine oxidase to amine metabolism and cardiovascular toxicity. Toxicol. Sci. 46, 386-392
7. Dai, X., Ou, X., Hao, X., Cao, D., Tang, Y., Hu, Y., Li, X. and Tang, C. (2008) Synthetic liver X receptor agonist T0901317 inhibits semicarbazide-sensitive amine oxidase gene expression and activity in apolipoprotein E knockout mice. Acta Biochim. Biophys. Sin. (Shanghai) 40, 261-268
8. del Mar Hernandez, M., Esteban, M., Szabo, P., Boada, M. and Unzeta, M. (2005) Human plasma semicarbazide sensitive amine oxidase (SSAO), beta-amyloid protein and aging. Neurosci. Lett. 384, 183-187
9. El Hadri, K., Moldes, M., Mercier, N., Andreani, M., Pairault, J. and Feve, B. (2002) Semicarbazide-sensitive amine oxidase in vascular smooth muscle cells: differentiation-dependent expression and role in glucose uptake. Arterioscler. Thromb. Vasc. Biol. 22, 89-94
10. Enrique-Tarancon, G., Marti, L., Morin, N., Lizcano, J. M., Unzeta, M., Sevilla, L., Camps, M., Palacin, M., Testar, X., Carpene, C. and Zorzano, A. (1998) Role of semicarbazide-sensitive amine oxidase on glucose transport and GLUT4 recruitment to the cell surface in adipose cells. J. Biol. Chem. 273, 8025-8032
11. Fitzgerald, D.H. and Tipton, K.F. (2002) Inhibition of monoamine oxidase modulates the behaviour of semicarbazide-sensitive amine oxidase (SSAO). J. Neural Transm. 109, 251-265
12. Gonzalez-Velasquez, F.J. and Moss, M.A. (2008) Soluble aggregates of the amyloid-beta protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells. J. Neurochem. 104, 500-513
13. Haider, N., Hochholdinger, I., Matyus, P. and Wobus, A. (2010) Synthesis of ortho-functionalized 4-aminomethylpyridazines as substrate-like semicarbazide-sensitive amine oxidase inhibitors. Chem. Pharm. Bull. (Tokyo) 58, 964-970
14. Hernandez, M., Sole, M., Boada, M. and Unzeta, M. (2006) Soluble semicarbazide sensitive amine oxidase (SSAO) catalysis induces apoptosis in vascular smooth muscle cells. Biochim. Biophys. Acta 1763, 164-173
15. Hernandez-Guillamon, M., Garcia-Bonilla, L., Sole, M., Sosti, V., Pares, M., Campos, M., Ortega-Aznar, A., Dominguez, C., Rubiera, M., Ribo,M., Quintana,M., Molina, C.A., varez-Sabin, J., Rosell, A., Unzeta, M. and Montaner, J. (2010) Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke. Stroke 41, 1528-1535
16. Holt, A., Smith, D.J., Cendron, L., Zanotti, G., Rigo, A. and Di Paolo, M.L. (2008) Multiple binding sites for substrates and modulators of semicarbazide-sensitive amine oxidases: kinetic consequences. Mol. Pharmacol 73, 525-538
17. Iffiu-Soltesz, Z., Wanecq, E., Lomba, A., Portillo, M.P., Pellati, F., Szoko, E., Bour, S., Woodley, J., Milagro, F.I., Alfredo, M.J., Valet, P. and Carpene, C. (2010) Chronic benzylamine administration in the drinking water improves glucose tolerance, reduces body weight gain and circulating cholesterol in high-fat diet-fed mice. Pharmacol. Res. 61, 355-363
18. Jaakkola, K., Kaunismaki, K., Tohka, S., Yegutkin, G., Vanttinen, E., Havia, T., Pelliniemi, L.J., Virolainen, M., Jalkanen, S. and Salmi, M. (1999) Human vascular adhesion protein-1 in smooth muscle cells. Am. J. Pathol. 155, 1953-1965
19. Jalkanen, S. and Salmi, M. (2008) VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation. Arterioscler. Thromb. Vasc. Biol. 28, 18-26
20. Jalkanen, S., Karikoski, M., Mercier, N., Koskinen, K., Henttinen, T., Elima, K., Salmivirta, K. and Salmi, M. (2007) The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding. Blood 110, 1864-1870
21. Kemik, O., Sumer, A., Kemik, A.S., Itik, V., Dulger, A.C., Purisa, S. and Tuzun, S. (2010) Human vascular adhesion protein-1 (VAP-1): serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease. World J. Surg. Oncol. 8, 83
22. Kinemuchi, H., Sugimoto, H., Obata, T., Satoh, N. and Ueda, S. (2004) Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues. Neurotoxicology 25, 325-335
23. Kiss, J., Jalkanen, S., Fulop, F., Savunen, T. and Salmi, M. (2008) Ischemia-reperfusion injury is attenuated in VAP-1-deficient mice and by VAP-1 inhibitors. Eur. J. Immunol. 38, 3041-3049
24. Koskinen, K., Vainio, P.J., Smith, D.J., Pihlavisto, M., Yla-Herttuala, S., Jalkanen, S. and Salmi, M. (2004) Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1). Blood 103, 3388-3395
25. Kurkijarvi, R., Adams, D.H., Leino, R., Mottonen, T., Jalkanen, S. and Salmi, M. (1998) Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases. J. Immunol. 161, 1549-1557
26. Langford, S.D., Trent, M.B. and Boor, P.J. (2002) Semicarbazide-sensitive amine oxidase and extracellular matrix deposition by smooth-muscle cells. Cardiovasc. Toxicol. 2, 141-150
27. Lizcano, J.M., Tipton, K.F. and Unzeta, M. (1998) Purification and characterization of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) from bovine lung. Biochem. J. 331, 69-78
28. Madej, A., Reich, A., Orda, A. and Szepietowski, J.C. (2007) Vascular adhesion protein-1 (VAP-1) is overexpressed in psoriatic patients. J. Eur. Acad. Dermatol. Venereol. 21, 72-78
29. Marinho, C., Arduino, D., Falcao, L.M. and Bicho, M. (2010) Alterations in plasma semicarbazide-sensitive amine oxidase activity in hypertensive heart disease with left ventricular systolic dysfunction. Rev. Port. Cardiol. 29, 37-47
30. Marttila-Ichihara, F., Auvinen, K., Elima, K., Jalkanen, S. and Salmi, M. (2009) Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumors. Cancer Res. 69, 7875-7883
31. Mercier, N., Moldes, M., El Hadri, K. and Feve, B. (2001) Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells. Biochem. J. 358, 335-342
32. Meszaros, Z., Szombathy, T., Raimondi, L., Karadi, I., Romics, L. and Magyar, K. (1999) Elevated serum semicarbazide-sensitive amine oxidase activity in non-insulin-dependent diabetes mellitus: correlation with body mass index and serum triglyceride. Metabolism Clin. Exp. 48, 113-117
33. Nemcsik, J., Szoko, E., Soltesz, Z., Fodor, E., Toth, L., Egresits, J., Tabi, T., Magyar, K. and Kiss, I. (2007) Alteration of serum semicarbazide-sensitive amine oxidase activity in chronic renal failure. J. Neural Transm. 114, 841-843
34. Nurminen, E. M., Pihlavisto, M., Lazar, L., Szakonyi, Z., Pentikainen, U., Fulop, F. and Pentikainen, O. T. (2010) Synthesis, in vitro activity, and three-dimensional quantitative structure-activity relationship of novel hydrazine inhibitors of human vascular adhesion protein-1. J. Med. Chem. 53, 6301-6315
35. Otsuka, S. and Kobayashi, Y. (1964) Radioisotopic assay for monoamine oxidase determinations in human plasma. Biochem. Pharmacol. 13, 995-1006
36. Plumb, J. A., Milroy, R. and Kaye, S.B. (1989) Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res. 49, 4435-4440
37. Salmi, M. and Jalkanen, S. (1995) Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models. Eur. J. Immunol. 25, 2803-2812
38. Smith, D. J., Salmi, M., Bono, P., Hellman, J., Leu, T. and Jalkanen, S. (1998) Cloning of vascular adhesion protein 1 reveals a novel multifunctional adhesion molecule. J. Exp. Med. 188, 17-27
39. Sole, M., Hernandez, M., Boada, M. and Unzeta, M. (2007) Characterization of A7r5 cell line transfected in a stable form by hSSAO/VAP-1 gene (A7r5 hSSAO/VAP-1 cell line). J. Neural Transm. 114, 763-767
40. Sole, M., Hernandez-Guillamon, M., Boada, M. and Unzeta, M. (2008) p53 phosphorylation is involved in vascular cell death induced by the catalytic activity of membrane-bound SSAO/VAP-1. Biochim. Biophys. Acta 1783, 1085-1094
41. Souto, R.P., Vallega, G., Wharton, J., Vinten, J., Tranum-Jensen, J. and Pilch, P.F. (2003) Immunopurification and characterization of rat adipocyte caveolae suggest their dissociation from insulin signaling. J. Biol. Chem. 278, 18321-18329
42. Stolen, C.M., Yegutkin, G.G., Kurkijarvi, R., Bono, P., Alitalo, K. and Jalkanen, S. (2004) Origins of serum semicarbazide-sensitive amine oxidase. Circ. Res. 95, 50-57
43. Togo, T., Akiyama, H., Iseki, E., Kondo, H., Ikeda, K., Kato, M., Oda, T., Tsuchiya, K. and Kosaka, K. (2002) Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J. Neuroimmunol. 124, 83-92
44. Town, T., Tan, J., Flavell, R.A. and Mullan, M. (2005) T-cells in Alzheimer's disease. Neuromol. Med. 7, 255-264
45. Unzeta, M., Sole, M., Boada, M. and Hernandez, M. (2007) Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease. J. Neural Transm. 114, 857-862
46. Vinters, H.V. (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18, 311-324
47. Vinters, H.V., Pardridge, W.M., Secor, D.L. and Ishii, N. (1988) Immunohistochemical study of cerebral amyloid angiopathy. II. Enhancement of immunostaining using formic acid pretreatment of tissue sections. Am. J. Pathol. 133, 150-162
48. Yegutkin, G.G., Salminen, T., Koskinen, K., Kurtis, C., McPherson, M.J., Jalkanen, S. and Salmi, M. (2004) A peptide inhibitor of vascular adhesion protein-1 (VAP-1) blocks leukocyte-endothelium interactions under shear stress. Eur. J. Immunol. 34, 2276-2285
49. Yraola, F., Albericio, F. and Royo, M. (2007) Inhibition of VAP1: quickly gaining ground as an anti-inflammatory therapy. Chem. Med. Chem. 2, 173-174
50. Yu, P.H., Lu, L.X., Fan, H., Kazachkov, M., Jiang, Z.J., Jalkanen, S. and Stolen, C. (2006) Involvement of semicarbazide-sensitive amine oxidase-mediated deamination in lipopolysaccharideinduced pulmonary inflammation. Am. J. Pathol. 168, 718-726